Is the biotech bubble still growing after all?

Considering that the first biotech IPO of 2014, Dicerna Pharmaceuticals, had its stock price up 160 percent as of mid-afternoon, you may be tempted to paraphrase Mark Twain in saying that the news of the death of the biotech bubble has been greatly exaggerated...